A 17-year-old boy with relapsed thoracic synovial sarcoma was prescribed pazopanib (starting dose 800 mg/d) as adjuvant therapy following successful surgical reintervention. During the following weeks, the boy’s brown hair and eyebrows gradually became white (in their newly growing part), a side-effect of pazopanib.
